Clinical Research Directory

Inclusion Criteria: * Hemiparetic patient who has had a stroke; * ischaemic or haemorrhagic stroke confirmed by CT or MRI; * female or male between 40 and 75 years of age; * subgroup 1: less than 3 months since stroke, * subgroup 2: more than 3 months but less than 1 year since stroke; * physical fitness adequate for the exertion of the treatment; * right or left lower limb involvement; * score 3 on the Functional Ambulation Categories (FAC) scale, i.e. Indicates a patient who can ambulate on a level surface without manual contact of another person but requires standby guarding of one person either for safety or verbal cueing; * or score 4 on the Functional Ambulation Categories (FAC) scale, i.e. Indicates a patient who can ambulate independently on a level surface but requires supervision to negotiate (e.g. stairs, inclines, non-flat surfaces); * be able to participate in therapy and cooperate based on cognitive function; * signed informed consent. Exclusion Criteria: * More than 1 year has passed since the stroke; * scores less than or equal to 3 on the Functional Ambulation Categories (FAC) scale; * patients who were unable to walk independently before the stroke; * patients treated with botulinum toxin in the lower limb in the last 3 months; * use of other lower limb advanced technology treatments during the study; * a person with limited capacity; * not physically able to bear weight; * severe aphasia (impairment of understanding or expression that severely impedes communication); * other condition that precludes the use of C-Mill or Andago: * severe emotional disturbance; * mentally incapacitated patient; * severe contracture or spasticity preventing the patient from being placed in the machine; * pregnancy; * skin disease in the area of contact with the straps; * fever; * unhealed fracture fracture; * inability to use the device due to weight and height limitations of the device; * epilepsy if you have had a seizure within a year; * severe visual impairment.